(Total Views: 374)
Posted On: 05/15/2019 2:16:23 PM
Post# of 72441
That April 9th PR also said.
"The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease."
5 weeks?? I know I know bobbleheads "most immediately" meant in Biotech Time....LOL
"The Company is now positioning itself to further advance Brilacidin, most immediately, in its planned Phase 3 Oral Mucositis program, and in mid-stage testing for Inflammatory Bowel Disease."
5 weeks?? I know I know bobbleheads "most immediately" meant in Biotech Time....LOL
(1)
(2)Scroll down for more posts ▼
